3460 related articles for article (PubMed ID: 35075058)
1. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
Negro F; Di Trana A; Marinelli S
Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
[TBL] [Abstract][Full Text] [Related]
2. [Not Available].
Bieri A; Kamber M; Sterchi M; Mullis PE
Ther Umsch; 2014 Apr; 71(4):245-52. PubMed ID: 24670606
[TBL] [Abstract][Full Text] [Related]
3. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
4. Doping control from a global and national perspective.
Fraser AD
Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
[TBL] [Abstract][Full Text] [Related]
5. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
Gosetti F; Mazzucco E; Gennaro MC; Marengo E
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
[TBL] [Abstract][Full Text] [Related]
6. Antidoping program: an important factor in the promotion and protection of the integrity of sport and athlete's health.
Mazzeo F; Monda V; Santamaria S; Nigro E; Valenzano A; Villano I; Cibelli G; Messina A; Messina G
J Sports Med Phys Fitness; 2018; 58(7-8):1135-1145. PubMed ID: 28738670
[TBL] [Abstract][Full Text] [Related]
7. Anti-doping and other sport integrity challenges during the COVID-19 pandemic.
Lima G; Muniz-Pardos B; Kolliari-Turner A; Hamilton B; Guppy FM; Grivas G; Bosch A; Borrione P; DI Gianfrancesco A; Fossati C; Pigozzi F; Pitsiladis Y
J Sports Med Phys Fitness; 2021 Aug; 61(8):1173-1183. PubMed ID: 34256541
[TBL] [Abstract][Full Text] [Related]
8. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
Vernec AR
Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
[TBL] [Abstract][Full Text] [Related]
9. Performance-enhancing drugs and the Olympics.
Watson CJ; Stone GL; Overbeek DL; Chiba T; Burns MM
J Intern Med; 2022 Feb; 291(2):181-196. PubMed ID: 35007384
[TBL] [Abstract][Full Text] [Related]
10. Substance use during the COVID-19 pandemic: What is really happening?
Mellos E; Paparrigopoulos T
Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
[TBL] [Abstract][Full Text] [Related]
11. Challenges and threats to implementing the fight against doping in sport.
Dvorak J; Saugy M; Pitsiladis YP
Br J Sports Med; 2014 May; 48(10):807-9. PubMed ID: 24764551
[TBL] [Abstract][Full Text] [Related]
12. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
Morente-Sánchez J; Zabala M
Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
[TBL] [Abstract][Full Text] [Related]
13. Investigating the use of stimulants in out-of-competition sport samples.
Boghosian T; Mazzoni I; Barroso O; Rabin O
J Anal Toxicol; 2011 Nov; 35(9):613-6. PubMed ID: 22080900
[TBL] [Abstract][Full Text] [Related]
14. [Medication, athletes and doping regulations].
Hartgens F
Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
[TBL] [Abstract][Full Text] [Related]
15. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
[TBL] [Abstract][Full Text] [Related]
16. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
Bloodworth A; McNamee M
Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
[TBL] [Abstract][Full Text] [Related]
17. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
Botrè F; de la Torre X; Donati F; Mazzarino M
Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
[TBL] [Abstract][Full Text] [Related]
18. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
Harcourt PR; Marclay F; Clothier B
Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
[TBL] [Abstract][Full Text] [Related]
19. Current anti-doping policy: a critical appraisal.
Kayser B; Mauron A; Miah A
BMC Med Ethics; 2007 Mar; 8():2. PubMed ID: 17394662
[TBL] [Abstract][Full Text] [Related]
20. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
Geyer H; Schänzer W; Thevis M
Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
